2 views left Get unlimited views with a free account

Subscribe to GlobalData Explorer

Take your business to the next level. Explore the latest trends and actionable insights to inform business strategy and pinpoint opportunities and risks.

Number of ongoing Clinical Trials (for drugs) involving Gliosarcoma by Phase

Industry: Pharmaceuticals
Current: Other Industry Indicators

There are currently 167 ongoing clinical trials involving Gliosarcoma
Of the 167 trials,65 trials are in Phase II
Furthermore, 41 trials are in Phase I

Number of ongoing Clinical Trials (for drugs) involving Gliosarcoma by Phase

View as table

The global pharmaceutical industry is steadily developing new drugs for Gliosarcoma, an oncology condition. The largest number of ongoing clinical trials for Gliosarcoma is conducted in North America. Asia-Pacific and Europe are among some of the other prominent regions engaged in Gliosarcoma-related drug trials.

National Cancer Institute US: The leading ongoing Gliosarcoma related clinical trial sponsor

National Cancer Institute US is the top sponsor for Gliosarcoma-related ongoing clinical trials.

Adult Brain Tumor Consortium, Dana-Farber Cancer Institute Inc, Dana-Farber/Harvard Cancer Center, and Sidney Kimmel Comprehensive Cancer Center are among other notable clinical trial sponsors involved in Gliosarcoma. A clinical trial sponsor can be a Company, Government, Individual, or Institution.